Further re Result of Subscription Rights Exercise

/**/

RNS Number : 5611M Golden Prospect Precious Metals Ltd 23 December 2025  

23 December 2025

Golden Prospect Precious Metals Limited (the "Company")   Further re Result of Subscription Rights Exercise for Ordinary Shares ​ Further to the announcement released on 3 December 2025, the Company confirms that net proceeds of the sale of the 3,718,555 new Ordinary Shares arising in respect of Subscription Rights not exercised have been paid at a rate of 34.7040361 pence per Ordinary Share. ​ For further information, please contact:





  Enquiries  



Manulife | CQS Investment Management       Craig Cleland  

  +44 (0) 20 7201 5368

Cavendish Capital Markets Limited Robert Peel (Corporate Finance) Daniel Balabanoff / Pauline Tribe (Sales)  

  +44 (0) 20 7908 6000 +44 (0) 20 7720 0500

Apex Fund and Corporate Services (Guernsey) Limited James Taylor  

  +44 (0) 203 5303 600

Tavistock Jos Simson / Gareth Tredway / Ruairi Millar

  +44 (0) 20 7920 3150

  About Golden Prospect Precious Metals  Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability in Guernsey on 16 October 2006. The Company's investment objective is to provide Shareholders with capital growth from a portfolio of companies involved in the precious metals sector. For the latest factsheet and other information, click here.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  FUREANAAALASFFA